Want to see HK:8049 full AI Analyst Report?
Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H (8049) Stock Statistics & Valuation Metrics
Total Valuation
Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H has a market cap or net worth of HKD 1.48B. The enterprise value is HKD 245.91M.
- Market Cap
- HKD 1.48B
- Enterprise Value
- HKD 245.91M
Share Statistics
Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H has 172,500,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 172,500,000
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H’s return on equity (ROE) is 0.12 and return on invested capital (ROIC) is 9.34%.
- Return on Equity (ROE)
- 0.12
- Return on Assets (ROA)
- 0.07
- Return on Invested Capital (ROIC)
- 9.34%
- Return on Capital Employed (ROCE)
- 0.12
- Revenue Per Employee
- 814.70K
- Profits Per Employee
- 179.66K
- Employee Count
- 1,107
- Asset Turnover
- 0.34
- Inventory Turnover
- 1.91
Valuation Ratios
The current PE Ratio of Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H is 4.46. Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H’s PEG ratio is 0.09.
- PE Ratio
- 4.46
- PS Ratio
- 1.13
- PB Ratio
- 0.69
- Price to FCF
- 0.00
- Price to Operating Cash Flow
- 0.00
- PEG Ratio
- 0.09
Income Statement
In the last 12 months, Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H had revenue of 901.87M and earned 198.88M in profits. Earnings per share was 0.35.
- Revenue
- 901.87M
- Gross Profit
- 757.67M
- Operating Income
- 214.60M
- Pretax Income
- 264.46M
- Net Income
- 198.88M
- EBITDA
- 294.19M
- Earnings Per Share (EPS)
- 0.35
Cash Flow
In the last 12 months, operating cash flow was 0 and capital expenditures 0, giving a free cash flow of 0 billion.
- Operating Cash Flow
- 0
- Free Cash Flow
- 0
- Free Cash Flow per Share
- 0.00
Dividends & Yields
Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H pays an annual dividend of HKD 0.27, resulting in a dividend yield of ―
- Dividend Per Share
- HKD 0.27
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 0.00%
- Earnings Yield
- 22.23%
Stock Price Statistics
- Beta
- 0.31
- 52-Week Price Change
- 23.26%
- 50-Day Moving Average
- 2.42
- 200-Day Moving Average
- 2.20
- Relative Strength Index (RSI)
- 66.65
- Average Volume (3m)
- 44.84K
Important Dates
Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H upcoming earnings date is Apr 01, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Aug 14, 2026
- Next Earnings Date
- Apr 01, 2027
- Ex-Dividend Date
- Jun 24, 2025
Financial Position
Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H as a current ratio of 1.30, with Debt / Equity ratio of 0.02%
- Current Ratio
- 1.30
- Quick Ratio
- 1.22
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- -0.49
- Interest Coverage Ratio
- 154.72
Taxes
In the past 12 months, Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H has paid 65.58M in taxes.
- Income Tax
- 65.58M
- Effective Tax Rate
- 0.25
Enterprise Valuation
Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H EV to EBITDA ratio is 3.06, with an EV/FCF ratio of 0.00.
- EV to Sales
- 0.92
- EV to EBITDA
- 3.06
- EV to Free Cash Flow
- 0.00
- EV to Operating Cash Flow
- 0.00
Balance Sheet
Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H has HKD 902.41M in cash and marketable securities with HKD 399.93K in debt, giving a net cash position of HKD 902.01M billion.
- Cash & Marketable Securities
- HKD 902.41M
- Total Debt
- HKD 399.93K
- Net Cash
- HKD 902.01M
- Net Cash Per Share
- HKD 5.23
- Tangible Book Value Per Share
- HKD 3.22
Margins
Gross margin is 84.61%, with operating margin of 26.13%, and net profit margin of 25.09%.
- Gross Margin
- 84.61%
- Operating Margin
- 26.13%
- Pretax Margin
- 32.86%
- Net Profit Margin
- 25.09%
- EBITDA Margin
- 30.00%
- EBIT Margin
- 26.20%
Analyst Forecast
The average price target for Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 0.20%
- EPS Growth Forecast
- 24.13%
Scores
- Smart Score
- ―
- AI Score
- 85
